Transparency Market Research published new market report"Drug Device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ,2013 - 2019" .The global drug device combination productsmarket was valued at USD 66.0 billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115.1 billion in 2019.This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion. Browse the report With Full TOC at http://www.transparencymarketresearch.com/drug-device-combination.html

1. Transparency Market Research
Drug Device Combination
Products Market - Global
Industry Analysis, Size,
Share, Growth, Trends and
Forecast, 2013 - 2019
Buy Now
Request Sample
Published Date: Dec 2013
Single User License: US $ 4795
Multi User License: US $ 7795
117 Pages Report
Corporate User License: US $ 10795
REPORT DESCRIPTION
Drug Device Combination Products Market is Expected to Reach USD 115.1 Billion
Globally in 2019: Transparency Market Research
Transparency Market Research is Published new Market Report “Drug Device
Combination Products Market (Drug Eluting Stents, Infusion Pumps,
Photosensitizers, Orthopedic Combination Products, Wound Care Combination
Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting
Beads)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013
- 2019," the global drug device combination productsmarket was valued at USD 66.0 billion
in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an
estimated value of USD 115.1 billion in 2019.
Drug device combination products are therapeutic products that combine a drug and a
medical device chemically and/or physically, to beproduced as a single product. These
products can be designed for local as well as systemic drug delivery.With the advances in
medical technology, medical devices have changed their definition to more complex devices
which assist in improving the efficiency of drugs in therapeutic treatments.These
innovations have also made it difficult for regulatory agencies to classify and provide
guidelines for safety and validation of these products.Newer developments in drug device

2. combination products have yielded several products for targeted drug delivery within the
body. Clinical trials for drug device combination products are more comprehensive and
expensive coupled with complications as compared to those required for individual drug and
device.
Growing elderly population combined with rise in risk for cardiovascular diseases, asthma
and various other chronic disorders contribute to the growth of this market particularly in
emerging economies of Middle East, India and China. Moreover, technological advancessuch
as biodegradable implants coupled with increase in access and recognition of these
technologies in emerging market, will serve as an opportunity for investors to invest in.
The global market for drug device combination products has been studied from the
perspective of current widely used various product types.The report provides a detailed
analysis of drug eluting stents which are segmented into coronary stents and peripheral
vascular stents while the infusion pumps include implantable infusion pumps and
ambulatory infusion pumps. Inhalers include metered dose inhalers, dry powder inhalers
and nebulizers. The others segment comprises intraocular implants and drug eluting beads.
The market estimations for transdermal patches, orthopedic combination products such as
bone graft implants and antibiotic loaded bone cements, wound care combination products
and photosensitizers have also been provided in the report for the forecast period 20132019.
The overall market for drug device combination products is fragmented owing to number of
small players involved in respective product segments. In 2012, transdermal patches
accounted for the largest share by revenue at USD 25.1 billion of the total drug device
combination products market. However, due to the product recalls and consequent stringent
regulatory approval procedures, the overall market revenue is expected to decline during
the forecast period in the U.S and Europe.The market for inhalers accounted for the second
largest share at over USD 20billion in 2012. It is estimated that the global market for
inhalers will grow at a CAGR of over 8% from 2013 to 2019, owing to its high incidence
rates of asthmatic and chronic obstructive pulmonary disease (COPD) patients.
Geographically, North America dominatedthe global market for drug device combination
products in terms of revenue generation and is expected to maintain its position throughout
the forecast period. Theadoption of drug eluting stents, implants, growing elderly population
and rise in incidences of hypertension and obesity in the U.S., is expected to contribute to
the leadership of the North American market. Europe was the second largest regional
market for drug device combination productsin 2012, owing to the increased demand for
drug eluting stents and infusion pumps.
The global drug device combination products market is dominated by few major players
including Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Inc.,
CareFusion Corporation and Allergen, Inc.
The global drug device combination products marketis segmented as follows:

3. Drug Device Combination Products Market, by Product Type

Drug Eluting Stents
o
o

Coronary Stents
Peripheral Vascular Stents
Infusion Pumps
o
Implantable Infusion Pumps
o
Ambulatory Infusion Pumps

Photosensitizers

Orthopedic Combination Products
o
Bone Graft Implants
o
Antibiotic Loaded Bone Cement

Wound Care Combination Products

Inhalers
o
Metered Dose Inhalers
o
Dry Powder Inhalers
o
Nebulizers

Transdermal Patches

Others
o
Intraocular Implants
o
Drug Eluting Beads
Drug Device Combination Products, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

4. Table of Content
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 Statistical Models
1.3.4 List of Abbreviations
1.3.5 Assumptions and Stipulations
Browse the full report with complete TOC at
http://www.transparencymarketresearch.com/drug-device-combination.html
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Definition and Overview
3.2 Market Drivers
3.2.1 Rise in aging population and consequent cases of chronic diseases worldwide
3.2.2 Increasing demand for minimally invasive products
3.3 Market Restraints
3.3.1 Infections from drug device combination products such as implants and associated
product recalls
3.4 Market Opportunities
3.4.1 Growth opportunities in emerging economies with high unmet needs
3.4.2 Introduction of biodegradable technology based products
3.5 Porter’s Five Forces Analysis: Global Drug Device Combination Products Market

5. 3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Drug Device Combination Products Market, by
Types
Related & Recently Published Reports by Transparency Market Research
Coal Fired Power Generation Market:
http://www.transparencymarketresearch.com/coal-fired-power-generationmarket.html
Amines Market: http://www.transparencymarketresearch.com/aminesmarket.html
Teleradiology Market:
http://www.transparencymarketresearch.com/teleradiology-technologyMarket.html
Orthobiologics Market:
http://www.transparencymarketresearch.com/orthobiologics-market.html
Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast,
2011-2019 (USD Billion)
4.1 Introduction
4.1.1 Global Drug Device Combination Products Market Revenue, 2011 - 2019 (USD
Billion)
4.2 Drug Eluting Stents
4.2.1 Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Billion)
4.2.2 Coronary Stents
4.2.2.1 Global Coronary Drug Eluting Stents Market, 2011-2019 (USD Billion)
4.2.3 Peripheral Vascular Stents

6. 4.2.3.1 Global Peripheral Vascular Drug Eluting Stents Market, 2011-2019 (USD
Billion)
4.3 Infusion Pumps
4.3.1 Global Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.3.2 Implantable Infusion Pumps
4.3.2.1 Global Implantable Infusion Pumps Market Revenue, 2011-2019 (USD
Billion)
4.3.3 Ambulatory Infusion Pumps
4.3.4 Global Ambulatory Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.4 Photosensitizers
4.4.1 Global Photosensitizers Market Revenue, 2011-2019 (USD Billion)
4.5 Orthopedic Combination Products
4.5.1 Global Orthopedic Combination Products Market Revenue, 2011-2019 (USD
Billion)
4.5.2 Antibiotic Bone Cement
4.5.3 Bone Graft Implants
4.6 Wound Care Combination Products
4.6.1 Antibiotic Wound Care Products
4.6.2 Global Wound Care Combination Products Market Revenue, 2011-2019 (USD
Billion)
4.7 Inhalers
4.7.1 Global Inhalers Market Revenue, 2011-2019 (USD Billion)
4.7.2 Nebulizers
4.7.2.1 Global Nebulizers Market Revenue, 2011-2019 (USD Billion)
4.7.3 Metered Dose Inhalers
4.7.3.1 Global Metered Dose Inhalers Market Revenue, 2011-2019 (USD Billion)
4.7.4 Dry Powder Inhalers

7. 4.7.4.1 Global Dry Powder Inhalers Market Revenue, 2011-2019 (USD Billion)
4.8 Transdermal Patches
4.8.1 Global Transdermal Patches Market Revenue, 2011-2019 (USD Billion)
4.9 Other Drug Device Combination Products
4.9.1 Global Other Drug Device Combination Products Market Revenue, 2011-2019
(USD Billion)
4.9.2 Intraocular Implants
4.9.3 Drug Eluting Beads
Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019
(USD Million)
5.1 Overview
5.1.1 Global Drug Device Combination Products Market, by Geography, 2011 - 2019
(USD Billion)
5.1.2 Global Drug Device Combination Products Market, by Geography, 2012 and 2019
(%)
5.2 North America
5.2.1 North America Drug Device Combination Products Market Revenue, 2011 – 2019
(USD Billion)
5.3 Europe
5.3.1 Europe Drug Device Combination Products Market Revenue, 2011 – 2019 (USD
Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Drug Device Combination Products Market Revenue, 2011 – 2019
(USD Billion)
5.5 Rest of the World
5.5.1 RoW Drug Device Combination Products Market Revenue, 2011 – 2019 (USD
Billion)

8. Chapter 6 Competitive Landscape
6.1 Market Share Analysis: Global Drug Device Combination Products Market
6.1.1 Methodology
6.1.2 Market Share Analysis for the global drug eluting stents market, by key players,
2012
6.1.3 Market share analysis for the global infusion pumps market, by key players, 2012
Chapter 7 Recommendations
7.1 Research and Development Initiatives
7.2 Converging Technologies to Yield Efficiencies
7.3 Mergers and Acquisitions to Improve Market Presence
7.4 Conducting Product Awareness Programs
7.5 Investing in Emerging Economies
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Allergan, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Recent Developments

9. 8.2.5 Business Strategies
8.3 Alcon, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Development
8.4 Arrow International, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Bausch & Lomb, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Recent Developments
8.5.5 Business Strategies
8.6 Boston Scientific Corporation
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.4.1 Acquisitions

10. 8.6.5 Recent Developments
8.7 CareFusion Corporation
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Covidien PLC
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 C.R. Bard, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Ethicon, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments

11. 8.11 Medline Industries, Inc.
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Medtronic, Inc.
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Development
8.13 Mylan, Inc.
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.5 Recent Developments
8.14 Pinnacle Biologics, Inc.
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.5 Recent Developments
8.15 Stryker Corporation

12. 8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies
8.16 Terumo Corporation
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4 Business Strategies
8.16.5 Recent Development
8.17 W. L. Gore & Associates, Inc.
8.17.1 Company Overview
8.17.2 Financial Overview
8.17.3 Product Portfolio
8.17.4 Recent Developments
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.

13. Contact:
Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse the full report with complete TOC at
http://www.transparencymarketresearch.com/drug-device-combination.html